Psychiatrist and psychedelics and bipolar researcher Dr. Josh Woolley (University of California San Francisco), and peer researcher Amir speak on psilocybin, ketamine, and psychedelics and their links with bipolar disorder, and what the science says about psychedelics as treatment.Â
Hosted by Dr. Erin Michalak. Â
Dr. Josh Woolley is currently the principal investigator and director of UCSFâs Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. The labâs mission is to understand mechanisms of social connection among individuals with mental illness and to test new treatments. The BAND Lab studies psychedelics as novel therapeutics for multiple conditions, including bipolar disorder. Heâs also the director of the translational psychedelic research program at UCSF.
#talkBD gathers researchers, people with lived experience, healthcare providers, and top bipolar disorder experts from around the world to discuss and answer the most important questions about living with bipolar disorder. Learn more about the talkBD Bipolar Disorder Podcast and upcoming episodes at https://talkBD.live